e.g. Tata motors, Reliance MF, 500570

Bafna Pharmaceuticals Ltd. - Research Center

532989 BAFNAPH Group (T) BSE data
 
Back to Company Page
Statement:

Balance sheet

(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Sources of funds
Owner's fund
Equity share capital 23.66 23.66 23.66 23.66 2.37
Share application money - - - - 55.36
Preference share capital - - - - -
Reserves & surplus 57.18 49.80 39.22 33.11 -6.78
Loan funds
Secured loans 24.39 22.92 7.89 2.50 3.02
Unsecured loans - - - - -
Total 105.23 96.38 70.77 59.27 53.96
Uses of funds
Fixed assets
Gross block 99.49 94.66 87.94 79.57 74.09
Less : revaluation reserve - - - - -
Less : accumulated depreciation 59.28 54.43 49.09 43.60 39.12
Net block 40.21 40.23 38.85 35.97 34.97
Capital work-in-progress 12.27 1.50 - 0.83 0.21
Investments - - - - -
Net current assets
Current assets, loans & advances 95.20 87.85 51.40 49.67 35.88
Less : current liabilities & provisions 42.45 33.20 19.47 27.19 17.10
Total net current assets 52.75 54.65 31.93 22.47 18.78
Miscellaneous expenses not written - - - - -
Total 105.23 96.38 70.77 59.27 53.96
Notes:
Book value of unquoted investments - - - - -
Market value of quoted investments - - - - -
Contingent liabilities 10.75 10.48 2.42 - -
Number of equity sharesoutstanding (Lacs) 236.56 236.56 236.56 236.56 23.66
Close
Add Bafna Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Bafna Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback